Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Series A Non-Voting Convertible Preferred Stock
Preferred Stock
Series A-1 Non-Voting Convertible Preferred Stock
Common Stock
Registered Direct Offering
Common Stock
Additional Paid-In Capital
Registered Direct Offering
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Registered Direct Offering
Total
Balances, Beginning at Dec. 31, 2024 $ 74,405,362                    
Balances, Beginning (in Shares) at Dec. 31, 2024 2,213.8044                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock $ 1,256,662                    
Balances, Ending at Mar. 31, 2025 $ 75,662,024 $ 24,994,461                  
Balances, Ending (in Shares) at Mar. 31, 2025 2,213.8044 284.2638                  
Balances, Beginning at Dec. 31, 2024       $ 133   $ 67,856,589 $ (73,818,946) $ (3,862,987) $ (299,128)   $ (10,124,339)
Balances, Beginning (in shares) at Dec. 31, 2024       1,332,178              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock   $ 24,994,461                 24,994,461
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock (in shares)   284.2638                  
Proceeds from issuance of common stock, net of fees     $ 58   $ 4,252,735         $ 4,252,793  
Proceeds from issuance of common stock, net of fees (in shares)     578,950                
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock           (1,256,662)         (1,256,662)
Share-based compensation expense           84,474         84,474
Net loss             (10,924,952)       (10,924,952)
Foreign currency translation adjustment               61,156     61,156
Balances, Ending at Mar. 31, 2025       $ 191   70,937,136 (84,743,898) (3,801,831) (299,128)   7,086,931
Balances, Ending (in shares) at Mar. 31, 2025       1,911,128              
Balances, Beginning at Dec. 31, 2024 $ 74,405,362                    
Balances, Beginning (in Shares) at Dec. 31, 2024 2,213.8044                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock                     (1,256,662)
Balances, Beginning at Dec. 31, 2024       $ 133   67,856,589 (73,818,946) (3,862,987) (299,128)   (10,124,339)
Balances, Beginning (in shares) at Dec. 31, 2024       1,332,178              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss                     (14,732,305)
Foreign currency translation adjustment                     3,595,698
Balances, Ending at Jun. 30, 2025 $ 75,662,024 $ 24,994,461   $ 191   71,001,615 (88,551,251) (267,289) (299,128)   6,878,599
Balances, Ending (in shares) at Jun. 30, 2025 2,269.1494 284.2638   1,911,128              
Balances, Beginning at Mar. 31, 2025 $ 75,662,024 $ 24,994,461                  
Balances, Beginning (in Shares) at Mar. 31, 2025 2,213.8044 284.2638                  
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Temporary Equity, Issuance of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock (in shares) 55.345                    
Balances, Beginning at Mar. 31, 2025       $ 191   70,937,136 (84,743,898) (3,801,831) (299,128)   7,086,931
Balances, Beginning (in shares) at Mar. 31, 2025       1,911,128              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock fees           (548)         (548)
Share-based compensation expense           65,027         65,027
Net loss             (3,807,353)       (3,807,353)
Foreign currency translation adjustment               3,534,542     3,534,542
Balances, Ending at Jun. 30, 2025 $ 75,662,024 $ 24,994,461   $ 191   71,001,615 (88,551,251) (267,289) (299,128)   6,878,599
Balances, Ending (in shares) at Jun. 30, 2025 2,269.1494 284.2638   1,911,128              
Balances, Beginning at Dec. 31, 2025                    
Balances, Beginning (in Shares) at Dec. 31, 2025                     0
Balances, Beginning at Dec. 31, 2025       $ 2,974   183,856,376 (108,076,316) (587,039) (299,128)   $ 74,896,867
Balances, Beginning (in shares) at Dec. 31, 2025       29,743,516              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Proceeds from issuance of common stock, net of fees       $ 234   11,397,225         11,397,459
Proceeds from issuance of common stock, net of fees (in shares)       2,338,948              
Exercise of Warrants       $ 132             132
Exercise of Warrants (in shares)       1,319,089              
Share-based compensation expense           449,419         449,419
Net loss             (4,986,614)       (4,986,614)
Foreign currency translation adjustment               (1,133,911)     (1,133,911)
Balances, Ending at Mar. 31, 2026       $ 3,340   195,703,020 (113,062,930) (1,720,950) (299,128)   80,623,352
Balances, Ending (in shares) at Mar. 31, 2026       33,401,553              
Balances, Beginning at Dec. 31, 2025                    
Balances, Beginning (in Shares) at Dec. 31, 2025                     0
Balances, Ending at Jun. 30, 2026                    
Balances, Ending (in Shares) at Jun. 30, 2026                     0
Balances, Beginning at Dec. 31, 2025       $ 2,974   183,856,376 (108,076,316) (587,039) (299,128)   $ 74,896,867
Balances, Beginning (in shares) at Dec. 31, 2025       29,743,516              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss                     (16,516,223)
Foreign currency translation adjustment                     (2,404,772)
Balances, Ending at Jun. 30, 2026       $ 3,363   196,246,223 (124,592,539) (2,991,811) (299,128)   68,366,108
Balances, Ending (in shares) at Jun. 30, 2026       33,629,553              
Balances, Ending at Jun. 30, 2026                    
Balances, Ending (in Shares) at Jun. 30, 2026                     0
Balances, Beginning at Mar. 31, 2026       $ 3,340   195,703,020 (113,062,930) (1,720,950) (299,128)   $ 80,623,352
Balances, Beginning (in shares) at Mar. 31, 2026       33,401,553              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of Warrants       $ 23             23
Exercise of Warrants (in shares)       228,000              
Share-based compensation expense           543,203         543,203
Net loss             (11,529,609)       (11,529,609)
Foreign currency translation adjustment               (1,270,861)     (1,270,861)
Balances, Ending at Jun. 30, 2026       $ 3,363   $ 196,246,223 $ (124,592,539) $ (2,991,811) $ (299,128)   $ 68,366,108
Balances, Ending (in shares) at Jun. 30, 2026       33,629,553